Orion Semi (Digoxin)

Orion Semi contains digoxin, a cardiac glycoside that acts on the cardiovascular system to improve cardiac efficiency.

• Atrial fibrillation: helps control ventricular rate by increasing vagal tone.
• Heart failure: modestly improves symptoms and exercise tolerance by increasing contractile force.
• Supraventricular tachycardia: assists in rate control when other agents are unsuitable.

• Digoxin inhibits the Na⁺/K⁺‑ATPase pump in cardiac myocytes, leading to an increase in intracellular sodium. This alteration promotes calcium influx via the Na⁺/Ca²⁺ exchanger, enhancing myocardial contractility while also stimulating vagal nerve activity to reduce heart rate.

Digoxin may cause a range of adverse reactions, most of which are dose‑related and require monitoring.

Common Side Effects

• Nausea and vomiting: mild gastrointestinal upset.
• Visual disturbances: blurred or yellow‑green vision.
• Fatigue: general tiredness or weakness.
• Headache: mild to moderate head pain.

Serious or Rare Side Effects

• Cardiac arrhythmias: potentially life‑threatening rhythm disturbances.
• Hyperkalemia: elevated potassium levels, especially in renal impairment.
• Severe bradycardia: markedly slow heart rate.
• Allergic reactions: rash, itching, or anaphylaxis.

When prescribing Orion Semi, clinicians should consider several safety measures.

• Renal function: adjust dose in patients with impaired clearance.
• Electrolyte balance: monitor potassium and magnesium levels.
• Drug interactions: review concomitant medications for additive effects.
• Thyroid disease: use caution in hyperthyroid patients.
• Pregnancy and lactation: evaluate risk‑benefit ratio carefully.
• Store at ambient temperature: keep in original container, protect from moisture and light.

Digoxin interacts with several medicines that can alter its plasma concentration or cardiac effects.

Major Interactions (Avoid)

• Amiodarone: increases digoxin levels, raising toxicity risk.
• Quinidine: reduces renal clearance, elevating serum concentrations.
• Verapamil: potentiates digoxin’s negative chronotropic effect.

Moderate Interactions (Monitor Closely)

• Diuretics (loop, thiazide): may cause electrolyte shifts that predispose to arrhythmias.
• ACE inhibitors: can lower potassium, enhancing toxicity potential.
• Beta‑blockers: additive bradycardic effect.
• Antacids containing aluminum or magnesium: may decrease absorption.